These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
93 related articles for article (PubMed ID: 498079)
1. Tumorigenicity and intracisternal A-particle expression of hybrids between murine myeloma and lymphocytes. Giacomoni D Cancer Res; 1979 Nov; 39(11):4481-4. PubMed ID: 498079 [TBL] [Abstract][Full Text] [Related]
2. Suppression of tumorigenicity in hybrids of tumorigenic Chinese hamster cells and diploid mouse fibroblasts: dependence on the presence of at least three different mouse chromosomes and independence of hamster genome dosage. Schäfer R; Hoffmann H; Willecke K Cancer Res; 1983 May; 43(5):2240-6. PubMed ID: 6831446 [TBL] [Abstract][Full Text] [Related]
3. Stable nontumorigenic phenotype of somatic cell hybrids between malignant Burkitt's lymphoma cells and autologous EBV-immortalized B cells despite induction of chromosomal breakage and loss. Jox A; Taquia E; Vockerodt M; Draube A; Pawlita M; Möller P; Bullerdiek J; Diehl V; Wolf J Cancer Res; 1998 Nov; 58(21):4930-9. PubMed ID: 9810002 [TBL] [Abstract][Full Text] [Related]
4. Suggestive evidence for functionally distinct, tumor-suppressor genes on chromosomes 1 and 11 for a human fibrosarcoma cell line, HT1080. Kugoh HM; Hashiba H; Shimizu M; Oshimura M Oncogene; 1990 Nov; 5(11):1637-44. PubMed ID: 2267132 [TBL] [Abstract][Full Text] [Related]
5. Protective effect of an interspecies hybridoma on the tumorigenicity of mouse myeloma cells. Baumal R; Marks A Cancer Res; 1981 Jul; 41(7):2598-604. PubMed ID: 7248932 [TBL] [Abstract][Full Text] [Related]
6. Inheritance of immunogenicity and metastatic potential in murine cell hybrids from the T-lymphoma ESb08 and normal spleen lymphocytes. Larizza L; Schirrmacher V; Stöhr M; Pflüger E; Dzarlieva R J Natl Cancer Inst; 1984 Jun; 72(6):1371-81. PubMed ID: 6610070 [TBL] [Abstract][Full Text] [Related]
7. Suppression of tumorigenicity in somatic cell hybrids. II. Human chromosomes implicated as suppressors of tumorigenicity in hybrids with Chinese hamster ovary cells. Klinger HP; Shows TB J Natl Cancer Inst; 1983 Sep; 71(3):559-69. PubMed ID: 6577230 [TBL] [Abstract][Full Text] [Related]
8. Tumor-specific immunity induced by somatic hybrids. I. Lack of relationship between immunogenicity and tumorigenicity of selected hybrids. Kim BS; Liang W; Cohen EP J Immunol; 1979 Aug; 123(2):733-8. PubMed ID: 88482 [TBL] [Abstract][Full Text] [Related]
9. Inhibition of tumorigenicity of a murine squamous cell carcinoma (SCC) cell line by a putative tumor suppressor gene on human chromosome 7. Zenklusen JC; Oshimura M; Barrett JC; Conti CJ Oncogene; 1994 Oct; 9(10):2817-25. PubMed ID: 8084587 [TBL] [Abstract][Full Text] [Related]
10. Multiple human chromosomes carrying tumor-suppressor functions for the mouse melanoma cell line B16-F10, identified by microcell-mediated chromosome transfer. Kugoh H; Nakamoto H; Inoue J; Funaki K; Barrett JC; Oshimura M Mol Carcinog; 2002 Nov; 35(3):148-56. PubMed ID: 12410566 [TBL] [Abstract][Full Text] [Related]
11. [Expression of malignancy traits in the interspecific somatic hybrids of tumor and normal cells]. Kakpakova ES Genetika; 1983 Nov; 19(11):1845-50. PubMed ID: 6317520 [TBL] [Abstract][Full Text] [Related]
12. Variants of an interspecies hybridoma with altered tumorigenicity and protective ability against mouse myeloma tumors. Baumal R; Musclow E; Farkas-Himsley H; Marks A Cancer Res; 1982 May; 42(5):1904-8. PubMed ID: 7066902 [TBL] [Abstract][Full Text] [Related]
13. Production of hybrids of mouse myeloma cells and protozoa which express parasite antigens. Rodriguez-Lopez MH; Crocker PR; Harrison TJ; Targett GA; Bradley DJ Immunology; 1984 Aug; 52(4):727-32. PubMed ID: 6378772 [TBL] [Abstract][Full Text] [Related]
14. [Somatic hybrids of normal and tumor Djzungarian hamster cells. II. Manifestation of malignancy and karyotype features of hybrid tumors]. Kakpakova ES; Malakhova EM; Massino IuS; Pogosiants EE Genetika; 1980; 16(8):1380-8. PubMed ID: 6257592 [TBL] [Abstract][Full Text] [Related]
15. Inhibition of established tumor growth in syngeneic mice by local inoculation of engineered mouse myeloma cells secreting a recombinant fusion protein RM4/TNF. Xiang J; Qi Y; Chen Y Cancer Gene Ther; 1997; 4(6):353-8. PubMed ID: 9408605 [TBL] [Abstract][Full Text] [Related]
16. Expression of collagenase IV (basement membrane collagenase) activity in murine tumor cell hybrids that differ in metastatic potential. Turpeenniemi-Hujanen T; Thorgeirsson UP; Hart IR; Grant SS; Liotta LA J Natl Cancer Inst; 1985 Jul; 75(1):99-103. PubMed ID: 2989606 [TBL] [Abstract][Full Text] [Related]
17. Expression of the teratocarcinoma phenotype in hybrids between totipotent mouse teratocarcinoma and myeloma cells. Correani A; Croce CM J Cell Physiol; 1980 Oct; 105(1):73-9. PubMed ID: 7430268 [TBL] [Abstract][Full Text] [Related]
18. Separation of ascites myeloma cells, lymphocytes and macrophages by zonal centrifugation on an isokinetic gradient. Stewart MJ; Pretlow TG; Hiramoto R Am J Pathol; 1972 Jul; 68(1):163-82. PubMed ID: 5080697 [TBL] [Abstract][Full Text] [Related]
19. Suppression of tumorigenicity in human cell hybrids derived from cell lines expressing different activated ras oncogenes. Geiser AG; Anderson MJ; Stanbridge EJ Cancer Res; 1989 Mar; 49(6):1572-7. PubMed ID: 2647289 [TBL] [Abstract][Full Text] [Related]
20. Fusion of plasmacytoma and host cells in vivo: selection of proliferating and nonproliferating cultures. Ber R; Lanir N J Natl Cancer Inst; 1984 Feb; 72(2):403-9. PubMed ID: 6582325 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]